Shares of US biotech Forte Biosciences shot up nearly 40% to $76.40 in early trading, on the news of a takeover bid from ...
US biotech Outlook Therapeutics revealed that the US Food and Drug Administration (FDA) has approved Lytenava ...
UK-based Novogene Europe, a multiomics research services partner, today announced that it has expanded its single-cell RNA ...
Cambridge Antibody Technology is the latest firm to join the Pfizer-Gen network of alliances, which Pfizer initiated in 1995 to expand its biotechnology expertise. As a result, CAT has signed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results